Coronavirus Outbreak


Covaxin: Bharat Biotech's coronavirus vaccine will be 60% effective, says top official

Bharat Biotech's 'Covaxin', a potential vaccine against the coronavirus infection, will be at least 60 per cent effective and the Indian biotechnology company is aiming to launch the coronavirus vaccine candidate in Q2 of 2021, confirmed a top official of the company. In an exclusive interview with India Today TV, Sai D Prasad, president, Quality Operations at Bharat Biotech, said while the company is aiming for at least 60 per cent effectiveness of the coronavirus vaccine candidate 'Covaxin', it could also be more. Bharat Biotech and ICMR are working on 'Covaxin', one of the indigenous coronavirus vaccine candidates being developed in India. Watch this video to know more.


Delhi govt increases fine for spitting in public to ? 2,000

A day after increasing the fine for not wearing masks from Rs 500 to Rs 2,000, the Delhi government announced the same penalty on Saturday for those caught violating quarantine rules, social distancing norms or chewing and spitting tobacco and pan masala. The Delhi Police imposed the fine of Rs 2,000 on more than 1,300 people in the city till 4 pm on Saturday. Watch this video to know more.

45,209 new coronavirus cases push India's Covid-19 caseload near 91 lakh

With a spike of 45,209 fresh coronavirus cases, India's Covid-19 caseload has climbed to 90,95,807, according to the Union health ministry.

Regeneron antibody therapy used to treat Trump for Covid gets US emergency approval

The U.S. Food and Drug Administration has approved Regeneron’s antibody therapy for emergency use. It is the same therapy that was administered to US President Donald Trump for coronavirus.

Bharat Biotech's Covid vaccine will be 60% effective, launch in Q2 of 2021, says top official

A top official at Bharat Biotech has told India Today TV that its coronavirus vaccine candidate 'Covaxin' will be at least 60 per cent effective and its launch is expected in Q2 of 2021.

Moderna will charge Rs 1,900-2,800 for coronavirus vaccine, says CEO

Moderna will charge governments between $25 and $37 per dose of its Covid-19 vaccine candidate, depending on the amount ordered, Chief Executive Stephane Bancel told German weekly Welt am Sonntag (WamS).

Steady rise in coronavirus cases in Mumbai in past couple days, shows data

In the past couple of days, data has shown that Mumbai has witnessed a steady rise in coronavirus cases.

Delhi Covid deaths go up by 111, health teams to visit home isolation patients, testing hiked

On a day when Delhi once again recorded over 100 deaths due to coronavirus, the Kejriwal government directed health teams to visit Covid-19 patients who are in home isolation and ensure they follow all norms. The government has also increased the capacity of RT-PCR testing capacity to 37,000 tests per day.

57 trainees of Mussoorie civil services training academy test Covid positive, admin on high-alert

The Academy is taking every measure to break the chain of Covid-19 spread.

Parliamentary panel on Covid: Pvt hosps charging huge sums, health spending abysmal

A Parliamentary panel on health has said in its report that with rising coronavirus cases and inadequate beds in government hospitals, private hospitals are charging exorbitant fees for treatment.

Former Assam CM Tarun Gogoi’s health worsens again after recovering from?Covid-19

The 86-year-old veteran politician was admitted at GMCH on November 2 due to post Covid-19 complications.

Rajasthan imposes night curfew in critical districts, public meetings banned in Jaipur after Covid surge

Rules have also been tightened for shops and markets where entry is banned without the use of masks.